Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt repayments
Ratios

Abvc Biopharma (ABVC) Accumulated Depreciation & Amortization (2018 - 2025)

Historic Accumulated Depreciation & Amortization for Abvc Biopharma (ABVC) over the last 12 years, with Q3 2025 value amounting to $3.4 million.

  • Abvc Biopharma's Accumulated Depreciation & Amortization fell 6850.17% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 6850.17%. This contributed to the annual value of $3.3 million for FY2024, which is 20.08% up from last year.
  • Abvc Biopharma's Accumulated Depreciation & Amortization amounted to $3.4 million in Q3 2025, which was down 6850.17% from $3.4 million recorded in Q2 2025.
  • Over the past 5 years, Abvc Biopharma's Accumulated Depreciation & Amortization peaked at $10.7 million during Q3 2024, and registered a low of $2856.0 during Q3 2021.
  • In the last 5 years, Abvc Biopharma's Accumulated Depreciation & Amortization had a median value of $11993.0 in 2021 and averaged $1.8 million.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first plummeted by 9991.0% in 2021, then skyrocketed by 14395083.79% in 2024.
  • Quarter analysis of 5 years shows Abvc Biopharma's Accumulated Depreciation & Amortization stood at $11993.0 in 2021, then surged by 98.44% to $23799.0 in 2022, then skyrocketed by 13913.37% to $3.3 million in 2023, then grew by 0.2% to $3.3 million in 2024, then grew by 1.28% to $3.4 million in 2025.
  • Its Accumulated Depreciation & Amortization was $3.4 million in Q3 2025, compared to $3.4 million in Q2 2025 and $3.3 million in Q1 2025.